Cancer Prevention and Treatment Fund president, Dr. Diana Zuckerman, testifies at an FDA advisory meeting on breast implants.
At an FDA advisory panel meeting on breast implants in August, three cancer patients testified about their experiences.
40 organizations including the Caner Prevention and Treatment signed onto this letter opposing the exemption of many cigars from FDA regulations.
July 29, 2011. The prestigious Institute of Medicine (IOM) released a report on the Food and Drug Administration’s 510(k) medical device clearance process stating the system is “flawed” and should be revised. The report echoes the National Research Center for Women & Families’ concerns about the lack of evidence that these devises actually work and are safe.
National Research Center of Women & Families President Diana Zuckerman testifies at the FDA meeting on Avastin.
National Research Center of Women & Families President Diana Zuckerman testifies at the FDA meeting on Avastin.